GENEVA, Sept. 18 -- NOVARTIS AG filed a patent application (IB2026/052216) for “TREATMENT OF ANCA-ASSOCIATED VASCULITIS USING A POPULATION OF CD19 CAR-EXPRESSING CELLS”. With publication no. WO/2026/185817, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 40/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....